United Therapeutics Insider Sold Shares Worth $5,650,415, According to a Recent SEC Filing

MT newswire2026/10/30 20:39

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:39 PM EDT, 10/30/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on October 29, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,650,415. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000175/xslF345X05/primarydocument.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.

华尔街见闻•2026/11/09 10:26